Recombinant Human CFTR Protein，His

Cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein that functions as a chloride channel and is crucial for maintaining ion balance and fluid secretion in various epithelial tissues. Mutations in the CFTR gene lead to cystic fibrosis (CF), a severe genetic disorder characterized by thick secretions in the lungs and digestive system, resulting in chronic infections, inflammation, and progressive lung damage. Due to its significant role in CF pathogenesis, CFTR has been a focal point of research aimed at understanding its structure and function, along with developing therapeutic strategies to correct CFTR dysfunction. Recent advances in protein engineering techniques have facilitated the production of recombinant CFTR proteins, allowing researchers to study its functional properties in isolation and in different cellular contexts. The development of these recombinant proteins has not only provided insights into the proper folding, trafficking, and gating mechanisms of CFTR but also has enabled the assessment of potential drugs aimed at restoring normal function in mutant CFTR variants. These studies are critical for advancing personalized medicine approaches for CF patients, including the evaluation of small molecules that can modulate CFTR activity, as well as gene therapy strategies aimed at correcting the underlying genetic defect. As such, the research into CFTR recombinant proteins is pivotal for unlocking new therapeutic avenues and improving the quality of life for individuals affected by cystic fibrosis.